Treatment of Tinnitus With Migraine Medications

Launched by UNIVERSITY OF CALIFORNIA, IRVINE · May 21, 2020

Keywords

ClinConnect Summary

This clinical trial is investigating whether certain medications used for treating migraines can help people who experience tinnitus, a condition often described as a ringing or buzzing in the ears. Tinnitus can be very distressing and can affect a person’s quality of life, leading to stress, anxiety, and depression. Currently, there are no medicines approved specifically for tinnitus, but this study aims to see if migraine medications can reduce the negative effects of tinnitus on daily living.

To participate in the study, you would need to be between 25 and 85 years old and have moderate to severe tinnitus. It's important that you can attend study visits and follow medication guidelines. However, if you are pregnant or have had a bad reaction to similar medications in the past, you would not be eligible to join. If you decide to participate, you’ll be monitored throughout the trial, and your experiences will help researchers understand how to better support those living with tinnitus.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with moderate to severe tinnitus.
• • Male or female between the ages of 25 to 85 years.
• • Subject must be compliant with the medication and attend study visits.
• • Must be able to read and write in the English language to provide consenting.
• Exclusion Criteria:
• • Pregnancy will result in automatic exclusion from the study. Rule out of pregnancy will be done by a urine pregnancy test to confirm the situation for all women who are of child bearing potential.
• • Subject with history of an adverse reaction to medication being prescribed.
• • Subject suffers from a medical condition or has history that may be concerning to the investigators clinical opinion.
• • All contraindications for the medications which prevent subjects from randomization will be considered as exclusion criteria.